Indegene Wins Global Tech Leadership Award for AI Pharma Commercialization

Indegene has received Frost & Sullivan's 2026 Global Enabling Technology Leadership Recognition for its AI-powered pharma commercialization services. The award acknowledges Indegene's success in transforming pharmaceutical commercialization workflows through domain-led AI, knowledge orchestration, and integrated execution. Frost & Sullivan highlighted Indegene's strategic effectiveness and execution in aligning AI with industry needs and scaling across various commercial, medical, and regulatory functions. The company's Pharma Operating System and Cortex reasoning engine were noted for enabling smarter decisions, faster execution, and measurable business outcomes at scale, enhancing customer value and market position.